Previsioni di mercato della bioelaborazione in Medio Oriente e Africa fino al 2031 - Analisi regionale - per prodotto (strumenti, materiali di consumo e accessori), scala di funzionamento (operazioni commerciali e cliniche), processo (bioprocesso a valle e bioprocesso a monte), applicazione (anticorpi monoclonali, vaccini, proteine ricombinanti, terapia cellulare e genica e altri) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)

BMIRE00030825 | Pages: 139 | Biotechnology | Oct 2024 | Type: Regional | Status: Published
Il mercato della bioelaborazione in Medio Oriente e Africa è stato valutato a 314,37 milioni di $ USA nel 2023 e si prevede che raggiungerà i 725,54 milioni di $ USA entro il 2031; si stima che registrerà un CAGR dell\'11,0% dal 2023 al 2031.

Il passaggio alla produzione automatizzata di terapie cellulari rafforza il mercato della bioelaborazione in Medio Oriente e Africa

Un numero crescente di terapie cellulari ha spostato la produzione di prodotti per la terapia cellulare da un piccolo volume a un grande volume in tutto il mondo. Le crescenti attività di ricerca nelle terapie cellulari hanno portato a un aumento della domanda di soluzioni di produzione avanzate. In considerazione di ciò, molti attori stanno offrendo prodotti per soddisfare le esigenze dei ricercatori accademici e delle grandi aziende biotecnologiche. Ad esempio, Lonza Cocoon e il sistema CliniMACS Prodigy di Miltenyi sono progettati per consentire l\'automazione della maggior parte delle operazioni unitarie sequenziali per un processo CAR-T all\'interno di un singolo sistema. Inoltre, l\'evoluzione della terapia cellulare, da un contesto accademico e clinico alla produzione e commercializzazione di massa, sta aumentando la domanda di automazione nella produzione. A maggio 2019, GE Healthcare ha lanciato l\'applicazione web Chronicle per supportare il flusso di lavoro completo della terapia cellulare. Il software di automazione Chronicle è una soluzione digitale conforme alle buone pratiche di produzione progettata per ottimizzare lo sviluppo e la produzione di complessi processi di terapia cellulare. Le aziende stanno anche avviando sviluppi strategici e tecnologici per l\'automazione nella terapia cellulare. Ad esempio, a luglio 2020, Thermo Fisher Scientific Inc. e Lyell Immunopharma hanno stretto una partnership per sviluppare e produrre processi per progettare terapie cellulari efficaci per i pazienti oncologici. Con questa partnership, le aziende mirano a migliorare l\'idoneità delle cellule T e supportare lo sviluppo di una piattaforma integrata conforme a cGMP (sistema e software) insieme a reagenti, materiali di consumo e strumenti. A marzo 2019, Lonza ha stretto una partnership con lo Sheba Medical Center di Israele per fornire una produzione CAR-T automatizzata e chiusa utilizzando la sua piattaforma di produzione di terapia cellulare Cocoon point-of-care. Le procedure automatizzate possono ridurre drasticamente i costi di produzione e migliorare la produttività del personale e i tassi di fidelizzazione. Oltre a questi fattori, i processi automatizzati limitano varie possibili fonti di contaminazione nell\'unità di produzione e alla fine migliorano la coerenza del processo, il che si traduce in prodotti di buona qualità complessiva riducendo gli errori manuali. Pertanto, la crescente adozione dell\'automazione tra i produttori di terapia cellulare e le crescenti innovazioni di prodotto nel campo della terapia cellulare probabilmente stimoleranno la bioelaborazione o la produzione della terapia cellulare.

Panoramica del mercato della bioelaborazione in Medio Oriente e Africa

Il mercato della bioelaborazione in Medio Oriente e Africa è segmentato in Arabia Saudita, Emirati Arabi Uniti, Sudafrica e resto del Medio Oriente e Africa. L\'Arabia Saudita detiene la quota maggiore del mercato in Medio Oriente e Africa. La crescente prevalenza di cancro, la crescente incidenza di disturbi immunologici, le iniziative favorevoli dei governi e un aumento delle attività di ricerca e sviluppo sono alcuni fattori che guidano il mercato in questa regione. I ministeri sauditi stanno firmando accordi con aziende biotecnologiche per l\'istituzione di strutture di produzione nel paese. In linea con ciò, si prevede che le strategie di espansione adottate dalle aziende internazionali per rafforzare la loro presenza in Medio Oriente e Africa andranno a beneficio del mercato della bioelaborazione nei prossimi anni.

Ricavi e previsioni del mercato della bioelaborazione in Medio Oriente e Africa fino al 2031 (milioni di $ USA)

Segmentazione del mercato della bioelaborazione in Medio Oriente e Africa

Il mercato della bioelaborazione in Medio Oriente e Africa è suddiviso in prodotto, scala di funzionamento, processo, applicazione, utente finale e paese.

In base al prodotto, il mercato della bioelaborazione in Medio Oriente e Africa è suddiviso in strumenti e materiali di consumo e accessori. Il segmento degli strumenti ha detenuto una quota di mercato maggiore nel 2023. Inoltre, il segmento degli strumenti è suddiviso in dispositivi di filtrazione, bioreattori, sistemi di cromatografia, centrifughe, dispositivi di essiccazione e altri. Inoltre, il sottosegmento dei bioreattori è suddiviso in scala pilota, scala completa e scala di laboratorio. Inoltre, il sottosegmento dei sistemi di cromatografia è suddiviso in cromatografia liquida, cromatografia gassosa e altri. Inoltre, il segmento dei materiali di consumo e degli accessori è suddiviso in reagenti, terreni di coltura cellulare, resine per cromatografia e altri.

In termini di scala operativa, il mercato della bioelaborazione del Medio Oriente e dell\'Africa è suddiviso in operazioni commerciali e operazioni cliniche. Il segmento delle operazioni commerciali ha detenuto una quota di mercato maggiore nel 2023.

In base al processo, il mercato della bioelaborazione del Medio Oriente e dell\'Africa è suddiviso in bioprocessi a valle e bioprocessi a monte. Il segmento dei bioprocessi a valle ha detenuto una quota di mercato maggiore nel 2023.

In base all\'applicazione, il mercato della bioelaborazione del Medio Oriente e dell\'Africa è suddiviso in anticorpi monoclonali, vaccini, proteine ricombinanti, terapia cellulare e genica e altri. Il segmento degli anticorpi monoclonali ha detenuto la quota di mercato più grande nel 2023.

In termini di utente finale, il mercato della bioelaborazione in Medio Oriente e Africa è suddiviso in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Il segmento delle aziende biofarmaceutiche ha detenuto la quota di mercato più grande nel 2023.

Per paese, il mercato della bioelaborazione in Medio Oriente e Africa è suddiviso in Arabia Saudita, Sudafrica, Emirati Arabi Uniti e resto del Medio Oriente e Africa. L\'Arabia Saudita ha dominato la quota di mercato della bioelaborazione in Medio Oriente e Africa nel 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc e Cytiva US LLC. sono alcune delle aziende leader che operano nel mercato della bioelaborazione in Medio Oriente e Africa.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodologys

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Bioprocessing Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Growing Biopharmaceutical Industry

4.2 Market Restraints

4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

4.3 Market Opportunities

4.3.1 Proliferating Demand for Personalized Medicine

4.4 Future Trends

4.4.1 Shift Toward Automated Cell Therapy Manufacturing

4.5 Impact of Drivers and Restraints:

5. Bioprocessing Market - Middle East & Africa Analysis

5.1 Middle East & Africa Bioprocessing Market Overview

5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

6. Middle East & Africa Bioprocessing Market Analysis - by Product

6.1 Overview

6.2 Instruments

6.2.1 Overview

6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

6.3 Consumables & Accessories

6.3.1 Overview

6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

7. Middle East & Africa Bioprocessing Market Analysis - by Scale of Operation

7.1 Overview

7.2 Commercial Operations

7.2.1 Overview

7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Clinical Operations

7.3.1 Overview

7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Bioprocessing Market Analysis - by Process

8.1 Overview

8.2 Downstream Bioprocess

8.2.1 Overview

8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Upstream Bioprocess

8.3.1 Overview

8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Middle East & Africa Bioprocessing Market Analysis - by Application

9.1 Overview

9.2 Monoclonal Antibodies

9.2.1 Overview

9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.4 Recombinant Protein

9.4.1 Overview

9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.5 Cell & Gene Therapy

9.5.1 Overview

9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Middle East & Africa Bioprocessing Market Analysis - by End User

10.1 Overview

10.2 Biopharmaceutical Companies

10.2.1 Overview

10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Contract Manufacturing Organization

10.3.1 Overview

10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Others

10.4.1 Overview

10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Middle East & Africa Bioprocessing Market - Country Analysis

11.1 Middle East & Africa

11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

11.1.1.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.1 Overview

11.1.1.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product

11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments

11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process

11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application

11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User

11.1.1.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.1 Overview

11.1.1.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product

11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments

11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process

11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application

11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User

11.1.1.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.5.1 Overview

11.1.1.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product

11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments

11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process

11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application

11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User

11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.7.1 Overview

11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product

11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments

11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process

11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application

11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Bioprocessing Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Getinge AB

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Thermo Fisher Scientific Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Sartorius AG

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Corning Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bio-Rad Laboratories Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 3M Co

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Eppendorf SE

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Agilent Technologies Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Cytiva US LLC

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Middle East & Africa Bioprocessing Market Segmentation

Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 6. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 7. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 8. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 9. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 10. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 11. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 12. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 13. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 14. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 15. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 16. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 17. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 18. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 19. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 20. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 21. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 22. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 23. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 24. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 25. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 26. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 27. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 29. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 30. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 31. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 32. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 33. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 34. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 35. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 36. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 37. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 38. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 39. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 40. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 41. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 43. Recent Organic Growth Strategies in the Bioprocessing Market

Table 44. Glossary of Terms, Bioprocessing Market

 

?

List of Figures

Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Growth Strategies in the Bioprocessing Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Agilent Technologies Inc
  10. Cytiva US LLC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440